For research use only. Not for therapeutic Use.
dCeMM4（Cat No.:I043870）is a selective inhibitor of cyclin-dependent kinase 8 (CDK8), a critical regulator of transcription and cell cycle processes. By inhibiting CDK8, dCeMM4 disrupts transcriptional activity and interferes with the expression of genes involved in cell proliferation, survival, and cancer progression. This compound has shown potential in cancer therapy, particularly in targeting cancers with dysregulated transcriptional regulation. Additionally, dCeMM4 may offer therapeutic benefits in inflammatory diseases and conditions with abnormal cell cycle control. Its specificity for CDK8 provides an advantage in minimizing off-target effects, making it a promising candidate for drug development.
| CAS Number | 1281683-44-0 |
| Synonyms | 3-(5-methylfuran-2-carbonyl)-N-(5-methyl-1,3-thiazol-2-yl)-1,3-thiazolidine-4-carboxamide |
| Molecular Formula | C14H15N3O3S2 |
| Purity | ≥95% |
| IUPAC Name | 3-(5-methylfuran-2-carbonyl)-N-(5-methyl-1,3-thiazol-2-yl)-1,3-thiazolidine-4-carboxamide |
| InChI | InChI=1S/C14H15N3O3S2/c1-8-3-4-11(20-8)13(19)17-7-21-6-10(17)12(18)16-14-15-5-9(2)22-14/h3-5,10H,6-7H2,1-2H3,(H,15,16,18) |
| InChIKey | BPWZJVKIVHVVHP-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(O1)C(=O)N2CSCC2C(=O)NC3=NC=C(S3)C |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
